Savonix – aiming for a world without dementia with an app that provides valuable information about your brain health and wellness.
Over the coming weeks, we will be bringing you extracts from 7 trailblazer profiles from our Aging in place Report. Each profile includes a flagship product deep dive as well as interoperability, target market, channels to market, success factors, IP and funding.
We also take a forensic overview with success grid and TRL assessment. Here’s the lowdown on Savonix.
Savonix- Aging in place trailblazer
Further, when Savonix’s data is used with other products and interventions, “real world evidence” can be provided to other businesses in the sector to aid product planning, research and development, and healthcare product marketing enhancement.
Longevity Potential: Savonix cognitive function predictor and support platform
Savonix’s mobile app incorporates its cutting-edge cognitive assessment software in a user-friendly package. With test bundles customised to screening use or clinical need, users can complete and view their cognitive assessment result with ease. Within 12 minutes a user can browse through their cognition, lifestyle and metabolic health readings alongside a comprehensive overview of their cognitive health. The support platform provides access to resources, giving the user content related to their results, receiving intervention programs and appointment scheduling with appropriate health care professionals if necessary.
Savonix software is supporting anyone with memory and brain health concerns to combat a population wide fear of cognitive degeneration, enabling early detection of cognitive risk, empowering individuals and their families to take steps early and allowing them to make appropriate preventative plans. The app’s educational content and connections to locally available resources support early intervention, which has been shown to give individuals the best chance to extend healthy life years. By enabling easy access to neuropsychologists, and or other specialists, who typically have wait times of several months, Savonix is driving healthcare accessibility for those most at risk of cognitive decline.
Savonix’s neuropsychological tests cover all cognitive domains and have been accessed for clinical validity, reliability, sensitivity and specificity. While comprehensive, Savonix can modularise testing into shorter sessions, across specified frequencies. For example, a 10-12 min test bundle is offered and is sensitive and specific to MCI. Beyond pure cognitive measures, Savonix also delivers a rich AI-driven composite cognitive risk score. The adaptive learning platform keeps up user engagement and ongoing monitoring and, at the same time, maps trends and trajectories as they respond to intervention.
This preventative intervention method is key in combating cognitive decline. This is because 40-60% of MCI is reversible if significant lifestyle changes are made. 1-3 lifestyle changes can include:
- Getting enough sleep
- Exercising more
- Increasing social interaction
- Incorporating a healthy diet
These are all changes Savonix provides advice upon, to create personalised care plans with the aim of improving individuals’ cognitive health.